Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype

Citation
Y. Endoh et al., Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype, AM J PATH, 157(3), 2000, pp. 717-722
Citations number
33
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
157
Issue
3
Year of publication
2000
Pages
717 - 722
Database
ISI
SICI code
0002-9440(200009)157:3<717:FHOTHG>2.0.ZU;2-#
Abstract
Hypermethylation of the hMLH1 mismatch repair gene promoter has been reveal ed to lead to microsatellite instability (MSI). Previously, we demonstrated a high prevalence of MSI in differentiated-type gastric tumors showing dis tinct features of gastric foveolar epithelium (foveolar type). To clarify t he significance of hMLH1 promoter hypermethylation in the development of th is tumor type, we studied promoter methylation status and expression of hML H1 in foveolar-type tumors and their surrounding non-neoplastic mucosae, as well as in tumors with other cellular phenotypes. The results were compare d to MSI status. After phenotypical analyses using mucin histochemistry and immunohistochemistry, 41 differentiated-type tumors with distinct cellular phenotypes were classified into three categories: foveolar type, intestina l type (tumors with the distinct cellular phenotype of the intestine), and combined type (tumors with both foveolar and intestinal phenotypes), Methyl ation-specific polymerase chain reaction (MSP) was performed to determine t he methylation status of hMLH1 promoter. hMLH1 protein expression was immun ohistochemically examined. MSI was detected in 57% of the foveolar type, 8% of the intestinal type, and 67% of the combined-type tumors. Hypermethylat ion of hMLH1 promoter was found in 74% of the foveolar type, 33% of the int estinal type, and 83% of the combined-type tumors. Of 18 MSI-positive tumor s, all but one were hypermethylated, Methylation status of hMLH1 promoter c orrelated well with protein expression in foveolar-type tumors. Moreover, h ypermethylation was also detected frequently (71%) in the non-neoplastic su rrounding mucosa of the hypermethylated tumors. Hypermethylation of hMLH1 p romoter is an initial, vital event in the development of foveolar-type tumo rs of the stomach.